Senores Pharmaceuticals IPO is to open on December 20, 2024. It is a Mainline IPO that will raise ā¹582.11 crores. The Senores Pharmaceuticals Services IPO price band is fixed at ā¹372 to ā¹391 with a market lot of 38 Shares.
Senores is one of the great pharmaceuticals focusing on generic medicine. It has also been certified by global food and drug authorities. Nowadays it is committed to providing good quality and manufacturing products to raise new demand in the global healthcare industry. At present, they have a goal of innovation, production, and manufacturing verticals and also have the vision to make more affordable and accessible healthcare, especially for varied types of products.
Moreover, they are providing a dynamic strategy, offering them access to products that are good to go. Noticeably, they have the strength of identifying, producing, specialty, underpenetrated, and complex pharmaceutical products, and received the reliability of customers to choose them over and over. It is focused on the US and Canadian markets, simultaneously 43 countries have also felt the presence of them. The company also manufactures critical care injectables and active pharmaceutical ingredients (APIs).
Senores Pharmaceuticals IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Kostak | Subject to |
| 30 December | ā¹280 |  | ā¹- | ā¹7,000 |
| 28 December | ā¹265 | | ā¹- | ā¹6,500 |
| 27 December | ā¹240 | | ā¹- | ā¹6,200 |
| 26 December | ā¹240 | | ā¹- | ā¹6,200 |
| 25 December | ā¹230 | | ā¹- | ā¹6,200 |
| 24 December | ā¹230 | | ā¹- | ā¹6,200 |
| 23 December | ā¹200 | | ā¹- | ā¹5,500 |
| 21 December | ā¹190 | | ā¹- | ā¹5,500 |
| 20 December | ā¹150 | | ā¹- | ā¹4,000 |
| 19 December | ā¹125 | | ā¹- | ā¹2,500 |
| 18 December | ā¹- | – | ā¹- | ā¹- |
| 17 December | ā¹- | – | ā¹- | ā¹- |
| 16 December | ā¹- | – | ā¹- | ā¹- |
Senores Pharmaceuticals IPO Details
| IPO Open Date: | December 20, 2024 |
| IPO Close Date: | December 24, 2024 |
| Face Value: | ā¹10 Per Equity Share |
| IPO Price Band: | ā¹372 to ā¹391 Per Share |
| Issue Size: | Approx ā¹582.11 Crores, 1,48,87,723 Equity Shares |
| Fresh Issue: | Approx ā¹500 Crores, 1,27,87,723 Equity Shares |
| Offer for Sale: | Approx ā¹82.11 Crores, 1,27,87,723 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 10% |
| QIB Quota: | Not more than 75% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Senores Pharmaceuticals IPO Dates
| IPO Open Date: | December 20, 2024 |
| IPO Close Date: | December 24, 2024 |
| Basis of Allotment: | December 26, 2024 |
| Refunds: | December 27, 2024 |
| Credit to Demat Account: | December 27, 2024 |
| IPO Listing Date: | December 30, 2024 |
Senores Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Senores Pharmaceuticals IPO GMP Today?
What is Senores Pharmaceuticals IPO Kostak Rate Today?
What is Senores Pharmaceuticals IPO Subject to Sauda Today?
What is Senores Pharmaceuticals IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Senores Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
